TB incidence and characteristics in the remote gulf province of Papua New Guinea: a prospective study

被引:25
作者
Cross, Gail B. [1 ,2 ]
Coles, Katie [1 ,2 ]
Nikpour, Mandana [3 ,4 ]
Moore, Owen A. [3 ]
Denholm, Justin [5 ]
McBryde, Emma S. [5 ]
Eisen, Damon P. [5 ]
Warigi, Beverlyn [2 ]
Carter, Robyn [7 ]
Pandey, Sushil [7 ]
Harino, Paul [2 ]
Siba, Peter [2 ]
Coulter, Christopher [7 ]
Mueller, Ivo [1 ,2 ,6 ,8 ]
Phuanukoonnon, Suparat [1 ,2 ]
Pellegrini, Marc [1 ,8 ]
机构
[1] Walter & Eliza Hall Inst Med Res, Infect & Immun Div, Parkville, Vic 3052, Australia
[2] Papua New Guinea Inst Med Res, Goroka 441, Eastern Highlan, Papua N Guinea
[3] St Vincents Hosp Melbourne, Dept Rheumatol, Fitzroy, Vic 3065, Australia
[4] Univ Melbourne, St Vincents Hosp Melbourne, Dept Med, Fitzroy, Vic 3065, Australia
[5] Royal Melbourne Hosp, Victorian Infect Dis Serv, Parkville, Vic 3050, Australia
[6] Barcelona Ctr Int Hlth Res, Barcelona, Spain
[7] Royal Brisbane & Womens Hosp Herston, Queensland Mycobacterium Reference Lab, Herston, Qld 4029, Australia
[8] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia
关键词
Papua New Guinea; Tuberculosis; Mycobacterium; Incidence; Drug resistance; MDR-TB; HIV; Kikori; GeneXpert; MYCOBACTERIUM-TUBERCULOSIS; MIRU-VNTRPLUS; HIV-INFECTION; EPIDEMIOLOGY; MULTICENTER; RESISTANCE; AFRICA; WOMEN;
D O I
10.1186/1471-2334-14-93
中图分类号
R51 [传染病];
学科分类号
100201 [内科学];
摘要
Background: The incidence and characteristics of tuberculosis (TB) in remote areas of Papua New Guinea (PNG) are largely unknown. The purpose of our study was to determine the incidence of TB in the Gulf Province of PNG and describe disease characteristics, co- morbidities and drug resistance profiles that could impact on disease outcomes and transmission. Methods: Between March 2012 and June 2012, we prospectively collected data on 274 patients presenting to Kikori Hospital with a presumptive diagnosis of TB, and on hospital inpatients receiving TB treatment during the study period. Sputum was collected for microscopy, GeneXpert analysis, culture and genotyping of isolates. Results: We estimate the incidence of TB in Kikori to be 1290 per 100,000 people (95% CI 1140 to 1460) in 2012. The proportion of TB patients co-infected with HIV was 1.9%. Three of 32 TB cases tested were rifampicin resistant. Typing of nine isolates demonstrated allelic diversity and most were related to Beijing strains. Conclusions: The incidence of TB in Kikori is one of the highest in the world and it is not driven by HIV co-infection. The high incidence and the presence of rifampicin resistant warrant urgent attention to mitigate substantial morbidity in the region.
引用
收藏
页数:10
相关论文
共 27 条
[1]
Evaluation and strategy for use of MIRU-VNTRplus, a multifunctional database for online analysis of genotyping data and phylogenetic identification of Mycobacterium tuberculosis complex isolates [J].
Allix-Beguec, Caroline ;
Harmsen, Dag ;
Weniger, Thomas ;
Supply, Philip ;
Niemann, Stefan .
JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (08) :2692-2699
[2]
Evaluation of the Analytical Performance of the Xpert MTB/RIF Assay [J].
Blakemore, Robert ;
Story, Elizabeth ;
Helb, Danica ;
Kop, JoAnn ;
Banada, Padmapriya ;
Owens, Michelle R. ;
Chakravorty, Soumitesh ;
Jones, Martin ;
Alland, David .
JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (07) :2495-2501
[3]
Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study [J].
Boehme, Catharina C. ;
Nicol, Mark P. ;
Nabeta, Pamela ;
Michael, Joy S. ;
Gotuzzo, Eduardo ;
Tahirli, Rasim ;
Gler, Ma Tarcela ;
Blakemore, Robert ;
Worodria, William ;
Gray, Christen ;
Huang, Laurence ;
Caceres, Tatiana ;
Mehdiyev, Rafail ;
Raymond, Lawrence ;
Whitelaw, Andrew ;
Sagadevan, Kalaiselvan ;
Alexander, Heather ;
Albert, Heidi ;
Cobelens, Frank ;
Cox, Helen ;
Alland, David ;
Perkins, Mark D. .
LANCET, 2011, 377 (9776) :1495-1505
[4]
CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21
[5]
García-Sancho MC, 2009, REV INVEST CLIN, V61, P392
[6]
TUBERCULOSIS AND HUMAN IMMUNODEFICIENCY VIRUS-INFECTION [J].
CHAISSON, RE ;
SLUTKIN, G .
JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (01) :96-100
[7]
Tuberculosis in Africa - Combating an HIV-driven crisis. [J].
Chaisson, Richard E. ;
Martinson, Neil A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (11) :1089-1092
[8]
Tuberculosis recurrence and mortality after successful treatment:: Impact of drug resistance [J].
Cox, Helen ;
Kebede, Yared ;
Allamuratova, Sholpan ;
Ismailov, Gabit ;
Davletmuratova, Zamira ;
Byrnes, Graham ;
Stone, Christine ;
Niemann, Stefan ;
Ruesch-Gerdes, Sabine ;
Blok, Lucie ;
Doshetov, Daribay .
PLOS MEDICINE, 2006, 3 (10) :1836-1843
[9]
HIV Infection-Associated Tuberculosis: The Epidemiology and the Response [J].
Getahun, Haileyesus ;
Gunneberg, Christian ;
Granich, Reuben ;
Nunn, Paul .
CLINICAL INFECTIOUS DISEASES, 2010, 50 :S201-S207
[10]
Hernández-Garduño E, 2004, INT J TUBERC LUNG D, V8, P377